Skip to main content

Advertisement

SpringerLink
Log in

Sex Steroids Block the Initiation of Atherosclerosis

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Atherosclerosis is the main cause of death in men and women. This so-called “hardening of the arteries” results from advanced atherogenesis, the accumulation and death of subendothelial fat-laden macrophages (vascular plaque). The macrophages are attracted as the result of signals from injured vessels recruiting and activating cells to quell the injury by inflammation. Among the recruited cells are circulating monocytes that may be captured by the formation of neural cell adhesion molecule (nCAM) tethers between the monocytes and vascular endothelium; the tethers are dependent on electrostatic binding between distal segments of apposed nCAM molecules. The capture of monocytes is followed by their entry into the subendothelial area as macrophages, many of which will remain and become the fat-laden foam cells in vascular plaque. Neural cell adhesion molecules are subject to sialylation that blocks their electrostatic binding. We showed that estradiol-induced nCAM sialylases are present in vascular endothelial cells and tested whether sex steroid pretreatment of human vascular endothelium could inhibit the capture of monocytes. Using in vitro techniques, pretreatment of human arterial endothelial cells with estradiol, testosterone, dehy-droepiandrosterone and dihydrotestosterone all induced sialylation of endothelial cells and, in a dose-response manner, reduced the capture of monocytes. Steroid hormones are protective against atherogenesis and its sequellae. Sex steroid depletion is associated with atherosclerosis. Based on this knowledge plus our results using sex steroid pretreatment of endothelial cells, we propose that the blockade of the initial step in atherogenesis by sex steroid-induced nCAM sialylation may be crucial to hormonal prevention of atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308(5728):1583–1587.

    Article  CAS  PubMed  Google Scholar 

  2. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet. 1998;351(9113):1425–427.

    Article  CAS  PubMed  Google Scholar 

  3. Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316(18):1105–1110.

    Article  CAS  PubMed  Google Scholar 

  4. Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE. Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med. 2009;122(11):1016–1022.

    Article  CAS  PubMed  Google Scholar 

  5. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907–3913.

    Article  CAS  PubMed  Google Scholar 

  6. Perez-Lopez FR, Chedraui P, Gilbert JJ, Perez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s health initiative era. Fertil Steril. 2009;92(4):1171–1186.

    Article  CAS  PubMed  Google Scholar 

  7. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  8. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981;139(1):47–51.

    Article  CAS  PubMed  Google Scholar 

  9. Shufelt CL, Merz CN, Prentice RL, et al. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study. Menopause. 2014;21(3):260–266.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985;313(17):1044–1049.

    Article  CAS  PubMed  Google Scholar 

  11. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133(12):933–941.

    Article  CAS  PubMed  Google Scholar 

  12. Manson JE. Postmenopausal hormone therapy and atherosclerotic disease. Am Heart J. 1994;128(6 pt 2):1337–1343. Review.

    Article  CAS  PubMed  Google Scholar 

  13. Ge QS, Tian QJ, Tseng H, Naftolin F. Development of low-dose reproductive hormone therapies in China. Gynecol Endocrinol. 2006;22(11):110.

    Article  CAS  Google Scholar 

  14. Clarkson TB, Meléndez GC, Appt SE. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Menopause. 2013;20(3):342–353.

    Article  PubMed  Google Scholar 

  15. Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women in The Kronos Early Estrogen Prevention Study (KEEPS): a randomized controlled trial. Ann Intern Med. 2014;161(4):249–260.

    Article  PubMed  Google Scholar 

  16. Hodis HN, Mack WJ, Shoupe D, et al. Testing the menopausal hormone therapy timing hypothesis: the early Vs late intervention trial with estradiol. Circulation. 2014;130(11):A13283.

    Google Scholar 

  17. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary artery calcification. N Engl J Med. 2007;256(11):2591–2602.

    Article  Google Scholar 

  18. Tan O, Harman SM, Naftolin F. What can we learn from design faults in the women’s health initiative randomized clinical trial? Bull NYU Hosp Jt Dis. 2009;67(2):226–229.

    PubMed  Google Scholar 

  19. Choi S, Steinberg E, Lee H, Naftalin F. The timing hypothesis remains a valid explanation of different cardioprotective effects of menopausal hormone treatment. Menopause. 2011;18(2):230–236.

    PubMed  Google Scholar 

  20. Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012;11(7):CD004143.

    Google Scholar 

  21. Garcia M, Miller VM, Gulati M, et al. Focused cardiovascular care for women: the need and role in clinical practice. Mayo Clin Proc. 2016;91(2):226–240.

    Article  PubMed  Google Scholar 

  22. Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–218.

    Article  CAS  PubMed  Google Scholar 

  23. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–2373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Diano S, Horvath TL, Mor G, et al. Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects. Menopause. 1999;6(1):21–28.

    CAS  PubMed  Google Scholar 

  25. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.

    Article  CAS  PubMed  Google Scholar 

  26. Libby P, Hansson GK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015; 116(2): 307-311.

    Google Scholar 

  27. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365–372.

    Article  CAS  PubMed  Google Scholar 

  28. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85(4):1260–1266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995;91(9):2488–2496.

    Article  CAS  PubMed  Google Scholar 

  30. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest. 1998;102(1):145–152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191(1):189–194.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Galkina E, Ley E. Vascular adhesion molecules in atherosclerosis. Atherioscler Thromb Vas Biol. 2007;27(11):2292–2301.

    Article  CAS  Google Scholar 

  33. Gascon E, Vutskits L, Kiss JZ. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev. 2007;56(1):101–118.

    Article  CAS  PubMed  Google Scholar 

  34. Mor G, Nilsen J, Horvath T, et al. Estrogen and microglia: a regulatory system that affects the brain. J Neurobiol. 1999;40(4):484–496.

    Article  CAS  PubMed  Google Scholar 

  35. Park H, Pagan L, Tan O, et al. Estradiol regulates expression of polysialated neural cell adhesion molecule by human vascular endothelial cells. Reprod Sci. 2010;17(12):1090–1098.

    Article  CAS  PubMed  Google Scholar 

  36. Kiss JZ, Rougon G. Cell biology of polysialic acid. Curr Opin Neurobiol. 1997;7(5):640–646.

    Article  CAS  PubMed  Google Scholar 

  37. Rougon G. Structure, metabolism and cell biology of polysialic acids. Eur J Cell Biol. 1993;61(2):197–207.

    CAS  PubMed  Google Scholar 

  38. Curatola AM, Huang K, Naftolin F. Dehydroepiandrosterone (DHEA) inhibition of monocyte binding by vascular endothelium is associated with sialylation of neural cell adhesion molecule. Reprod Sci. 2012;19(1):86–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, New York University, 180 Varick St #627, New York, NY, 10014, USA

    Frederick Naftolin MD, PhD, Holly Mehr MD, MSEd & Ahmed Fadiel MS, PhD

Authors
  1. Frederick Naftolin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holly Mehr MD, MSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Fadiel MS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frederick Naftolin MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naftolin, F., Mehr, H. & Fadiel, A. Sex Steroids Block the Initiation of Atherosclerosis. Reprod. Sci. 23, 1620–1625 (2016). https://doi.org/10.1177/1933719116674078

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116674078

Keywords

Search

Navigation